News

Applied Clinical Trials and SCORR Marketing recently conducted this survey to gain insight on the challenges the health science industry is facing to ensure drug products and biomarker samples are getting to the right place, at the right time, in the right way. The survey report also includes information on inventory related issues, utilization of technological solutions, challenges at different points in the delivery process, drug product tracking and predictions on future trends in clinical supply chain management.

The FDA has signed a Cooperative Research and Development Agreement (CRADA) with CluePoints for its Central Statistical Monitoring solution.

Boston and Chicago-based academic research organization Alliance Foundation Trials (AFT) has selected Wingspan’s eTMF and Site Zone life science solutions.

Picture1.png

As biopharma companies continue to explore and experience ways in which risk-based monitoring is implemented, the process of such can be misconstrued. Peter Schiemann elaborates on some of the current issues of RBM interpretation and implementation.

EMA Updates Activities

The EMA has appointed Grzegorz Cessak as its vice-chair of management for the next three years.

Globalization has increasingly become a part of the clinical trial landscape as pharma sponsors conduct trials internationally. With language barriers being among the challenges of this process, translation management is now a must during the planning phase of a global trial.